These alterations were spatially localized to proximal tubules and coincided with marked collagen deposition.<h4>Conclusion</h4>This study identifies METTL17 and SLC27A1 as key mediators of CKD progression, bridging mitochondrial dysfunction, metabolic reprogramming, and immune imbalance. This evidence concerns the gene METTL17 and chronic kidney disease.